Beer S, Kesselring J
Klinik für Neurologie, Abteilung für klinische Neurophysiologie, Kantonsspital St. Gallen.
Schweiz Med Wochenschr. 1991 Jun 29;121(26):961-9.
Since the 1950s steroids have been known to have a beneficial effect on recovery from acute exacerbations of multiple sclerosis. The main effect is a more rapid improvement after acute relapses due to resolution of edema in the central nervous system. Long-term steroid therapy showed no benefit in patients with a progressive course and involves dangerous side effects (Cushing's habitus, hyperglycemia, increased susceptibility to infections, peptic ulcers, osteoporosis, cataract). Intrathecal steroid administration offered no advantage over the conventional i.v. route. On the basis of a multicentre trial, ACTH therapy became the standard regime in the treatment of acute exacerbations. Recent reports have demonstrated a beneficial effect of therapy with high-dose methylprednisolone. Taking into account the restrictions and possible side effects, this therapy is a safe and efficient alternative to the standard ACTH regimen in the treatment of acute exacerbations in multiple sclerosis.
自20世纪50年代以来,人们就知道类固醇对多发性硬化症急性加重期的恢复有有益作用。主要作用是急性复发后由于中枢神经系统水肿消退而更快改善。长期类固醇治疗对病程呈进行性的患者没有益处,且会带来危险的副作用(库欣体态、高血糖、感染易感性增加、消化性溃疡、骨质疏松、白内障)。鞘内注射类固醇与传统静脉注射途径相比没有优势。基于一项多中心试验,促肾上腺皮质激素疗法成为治疗急性加重期的标准方案。最近的报告表明高剂量甲基强的松龙治疗有有益作用。考虑到限制因素和可能的副作用,这种疗法在治疗多发性硬化症急性加重期时是标准促肾上腺皮质激素方案的一种安全有效的替代方法。